References
Hesse B, Vinberg N, Berthelsen AK, Ballinger JR. Adverse events in nuclear medicine – cause for concern? Eur J Nucl Med Mol Imaging. doi:10.1007/s00259-012-2071-6
Santos-Oliveira R, Machado M. Pitfalls with radiopharmaceuticals. Am J Med Sci. 2011;342:50–3.
Silberstein EB, Ryan J. Prevalence of adverse reactions in nuclear medicine. Pharmacopeia Committee of the Society of Nuclear Medicine. J Nucl Med. 1996;37:185–92.
Hesslewood SR, Keeling DH. Frequency of adverse reactions to radiopharmaceuticals in Europe. Eur J Nucl Med. 1997;24:1179–82.
Silberstein EB. Prevalence of adverse reactions to positron emitting radiopharmaceuticals in nuclear medicine. Pharmacopeia Committee of the Society of Nuclear Medicine. J Nucl Med. 1998;39:2190–2.
Kusakabe K, Okamura T, Kasagi K, Komatani A, Sato Y, Matsuda H, et al. The 27th report on survey of the adverse reaction to radiopharmaceuticals (the 30th survey in 2004). Kaku Igaku. 2006;43:23–35.
Kusakabe K, Arano Y, Okamura T, Kasagi K, Komatani A, Matsuda H, et al. The 28th report on survey of the adverse reaction to radiopharmaceuticals (the 31st survey in 2005). Kaku Igaku. 2007;44:29–42.
Kusakabe K, Arano Y, Okamura T, Kasagi K, Komatani A, Matsuda H, et al. The 29th report on survey of the adverse reaction to radiopharmaceuticals (the 32nd survey in 2006). Kaku Igaku. 2008;45:19–35.
Matsuda H, Arano Y, Okazawa H, Okamura T, Mizumura S, Yokoyama K, et al. The 30th report on survey of the adverse reaction to radiopharmaceuticals (the 33rd survey in 2007). Kaku Igaku. 2009;46:29–41.
EANM Radiopharmacy Committee. http://www.eanm.org/committees/radiopharmacy/edu.php?navId=226
Hesslewood SR. European system for reporting adverse reactions to and defects in radiopharmaceuticals: annual report 2000. Eur J Nucl Med Mol Imaging. 2002;29:BP13–19
Nota Informativa Importante su Scintimun (besilesomab) (10/11/2011) http://www.agenziafarmaco.gov.it/it/content/nota-informativa-importante-su-scintimun-besilesomab-10112011
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Salvatori, M., Treglia, G. & Mores, N. Further considerations on adverse reactions to radiopharmaceuticals. Eur J Nucl Med Mol Imaging 39, 1360–1362 (2012). https://doi.org/10.1007/s00259-012-2120-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00259-012-2120-1